206
Participants
Start Date
November 12, 2018
Primary Completion Date
February 4, 2020
Study Completion Date
January 26, 2021
VOLUX XC
Participants will be treated with VOLUX XC hyaluronic acid (HA) injectable gel on day 1 with optional touch-up at day 30 and optional maintenance treatment at Month 12.
No-treatment control
No-treatment during the control period. Optional delayed-treatment with VOLUX XC (initial with optional touch-up) at the beginning of the Post-Control period.
Center aesthetic and dermatology, New York
Laser & Skin Surgery Center of New York, New York
The Center for Dermatology, Cosmetic & Laser Surgery, Mount Kisco
Williams Center, Latham
Center for Dermatology and Dermatologic Surgery, Washington D.C.
Callender Center for Clinical Research, Glenn Dale
MDLSV, Hunt Valley
SkinDC, Arlington
Aesthetic Solutions, PA., Chapel Hill
Hevia Cosmetic Dermatology, Coral Gables
Baumann Cosmetic and Research Institute, Miami
Skin Research Institute LLC, Coral Gables
Susan H Weinkle, MD, Bradenton
Total Skin and Beauty Dermatology Center, PC, Birmingham
DeNova Research dba Arano, LLC, Chicago
Suzanne Bruce and Associates, P.A., The Center for Skin Research, Houston
Bellaire Dermatology Associates, Bellaire
Westside Aesthetics, Los Angeles
Artemedica, Santa Rosa
Lead Sponsor
Allergan
INDUSTRY